TY - JOUR
T1 - Characteristic features and progression of abnormalities on MRI for CARASIL
AU - Nozaki, Hiroaki
AU - Sekine, Yumi
AU - Fukutake, Toshio
AU - Nishimoto, Yoshinori
AU - Shimoe, Yutaka
AU - Shirata, Akiko
AU - Yanagawa, Sohei
AU - Hirayama, Mikio
AU - Tamura, Masato
AU - Nishizawa, Masatoyo
AU - Onodera, Osamu
N1 - Publisher Copyright:
© © 2015 American Academy of Neurology.
PY - 2015/8/4
Y1 - 2015/8/4
N2 - Objectives: The objective of this study was to clarify the characteristic brain MRI findings for genetically diagnosed CARASIL (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy). Methods: Seven patients with CARASIL carrying HTRA1 mutations (representing 6 Japanese families) were included in this study. Eighteen brain MRIs were reviewed and evaluated with a new rating scale based on scoring for abnormal hyperintense lesions and atrophy. Results: At the last follow-up MRI, all patients had hyperintense lesions on T2-weighted images of the frontal white matter, anterior temporal lobe, external capsules, and thalami. Patients with longer time from the onset of cognitive impairment had higher MRI severity score. The atrophy advanced, followed by white matter lesion progression. During the early stage, hyperintense lesions were observed in the frontal white matter, external capsule, and pons. During the late stage, the arc-shaped hyperintense lesion from the pons to the middle cerebellar peduncles, which we designated the "arc sign," became evident. The arc sign was a characteristic finding for CARASIL in the advanced stage. Conclusions: These characteristic MRI findings for CARASIL are useful for selecting patients for genetic testing. The rating scale correlates well with disease duration and might be useful for assessing disease progression.
AB - Objectives: The objective of this study was to clarify the characteristic brain MRI findings for genetically diagnosed CARASIL (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy). Methods: Seven patients with CARASIL carrying HTRA1 mutations (representing 6 Japanese families) were included in this study. Eighteen brain MRIs were reviewed and evaluated with a new rating scale based on scoring for abnormal hyperintense lesions and atrophy. Results: At the last follow-up MRI, all patients had hyperintense lesions on T2-weighted images of the frontal white matter, anterior temporal lobe, external capsules, and thalami. Patients with longer time from the onset of cognitive impairment had higher MRI severity score. The atrophy advanced, followed by white matter lesion progression. During the early stage, hyperintense lesions were observed in the frontal white matter, external capsule, and pons. During the late stage, the arc-shaped hyperintense lesion from the pons to the middle cerebellar peduncles, which we designated the "arc sign," became evident. The arc sign was a characteristic finding for CARASIL in the advanced stage. Conclusions: These characteristic MRI findings for CARASIL are useful for selecting patients for genetic testing. The rating scale correlates well with disease duration and might be useful for assessing disease progression.
UR - http://www.scopus.com/inward/record.url?scp=84938571212&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84938571212&partnerID=8YFLogxK
U2 - 10.1212/WNL.0000000000001803
DO - 10.1212/WNL.0000000000001803
M3 - Article
C2 - 26138950
AN - SCOPUS:84938571212
SN - 0028-3878
VL - 85
SP - 459
EP - 463
JO - Neurology
JF - Neurology
IS - 5
ER -